98%
921
2 minutes
20
Purpose: Oxamate is a well-known inhibitor of glycolysis. However, its broad inhibitory effects on whole-body energy metabolism in vivo have not been identified. Therefore, we aimed to investigate its effects on wholebody energy metabolism in mice.
Methods: Ten-week-old male ICR mice were used in this study. The resting metabolic rate was measured for 3 h immediately after the intraperitoneal injection of oxamate (750 mg/kg) using a metabolic chamber system. In addition, resting blood glucose and lactate concentrations were measured. Next, the metabolism during exercise (10-25 m/min) was measured for 30 min immediately after oxamate injection using a metabolic treadmill chamber system. Post-exercise blood lactate concentrations were measured immediately after exercise sessions.
Results: The resting respiratory exchange rate remained unchanged, but fat and carbohydrate oxidation and energy expenditure (p = 0.003, 0.049, and 0.002, respectively) were significantly suppressed following oxamate injection. While the resting blood glucose levels were significantly reduced (p = 0.002), the lactate levels were significantly elevated (p = 0.005). The respiratory exchange rate during exercise significantly increased by oxamate injection (p = 0.02). Although fat oxidation during exercise significantly reduced (p = 0.009), carbohydrate oxidation remained unchanged. Consequently, energy expenditure during exercise was significantly reduced (p = 0.024) and post-exercise blood lactate levels were significantly elevated (p = 0.005) by oxamate injection.
Conclusion: Oxamate suppressed whole-body energy metabolism by inhibiting fat oxidation and altering lactate dynamics in vivo. These results provide novel insights into the systemic metabolic effects of oxamate and highlight the need for further investigation of its impact under different physiological conditions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12325871 | PMC |
http://dx.doi.org/10.20463/pan.2025.0011 | DOI Listing |
Crit Rev Food Sci Nutr
September 2025
Hunan Key Laboratory of Deep Processing and Quality Control of Cereals and Oils, State Key Laboratory of Utilization of Woody Oil Resource, College of Food Science and Engineering, Central South University of Forestry and Technology, Changsha, Hunan, China.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition that results from metabolic disorders. In addition to genetic factors, irregular and high-energy diets may also significantly contribute to its pathogenesis. Dietary habits can profoundly alter the composition of gut microbiota and metabolites.
View Article and Find Full Text PDFJ Anim Sci
September 2025
Centre for Veterinary Systems Transformation and Sustainability, Clinical Department for Farm Animals and Food System Science, University of Veterinary Medicine Vienna, Vienna 1210, Austria.
It is helpful for diagnostic purposes to improve our current knowledge of gut development and serum biochemistry in young piglets. This study investigated serum biochemistry, and gut site-specific patterns of short-chain fatty acids (SCFA) and expression of genes related to barrier function, innate immune response, antioxidative status and sensing of fatty and bile acids in suckling and newly weaned piglets. The experiment consisted of two replicate batches with 10 litters each.
View Article and Find Full Text PDFArch Microbiol
September 2025
Medical and Biological Computing Laboratory, School of Biosciences and Technology (SBST), Vellore Institute of Technology (VIT), Vellore, 632014, India.
Salmonella enterica serovar Typhi, the etiological agent of Typhoid fever, remains a critical public health concern associated with high morbidity in many developing countries. The widespread emergence of multidrug-resistant (MDR) Salmonella Typhi strains against the fluoroquinolone group of antibiotics, particularly ciprofloxacin, poses a significant global therapeutic challenge with underlying resistance due to mutations in quinolone-resistance determining region (QRDR) of gyrA gene, encoding DNA gyrase subunit A (GyrA). In pursuit of alternative therapeutic candidates, the present study was designed to evaluate ciprofloxacin analogues against prevalent GyrA mutations (S83F, D87G, and D87N) to overcome fluoroquinolone resistance through machine learning (ML)-based approach.
View Article and Find Full Text PDFmSystems
September 2025
Department of Biological Sciences and BioDiscovery Institute, University of North Texas, Denton, Texas, USA.
is a human fungal pathogen that survives and proliferates within phagocytic immune cells. To sustain growth in the nutrient-limited phagosome environment, the pathogenic yeast scavenges available carbon sources, which must be metabolized through central carbon metabolism for respiration and biomass synthesis. However, carbon metabolic pathways operating in the pathogenic yeast phase have not been extensively mapped.
View Article and Find Full Text PDFAppl Environ Microbiol
September 2025
Biofuels Institute, School of Emergency Management, School of the Environment and Safety Engineering, Jiangsu University, Zhenjiang, Jiangsu, PR China.
is a thermophilic acetogenic bacterium capable of thriving at elevated temperatures up to 66°C. It metabolizes carbohydrates such as glucose, mannose, and fructose and can also grow lithotrophically utilizing hydrogen (H) and carbon dioxide (CO) or carbon monoxide (CO), with acetate serving as its main product. A simple and efficient genome editing system for would not only facilitate the understanding of the physiological function of enzymes involved in energy and carbon metabolism but also enable metabolic engineering.
View Article and Find Full Text PDF